Time filter

Source Type

Zhong Y.,Shanghai JiaoTong University | Zhao J.,Jin Shan Branch Hospital of Sixth Peoples Hospital of Shanghai | Gu Y.-J.,Jin Shan Branch Hospital of Sixth Peoples Hospital of Shanghai | Zhao Y.-F.,Jin Shan Branch Hospital of Sixth Peoples Hospital of Shanghai | And 2 more authors.
Archives of Gerontology and Geriatrics | Year: 2015

Objective: Most publications describe cathepsin B and L as tumor and metastasis factors. These proteases also play a very important role in aging process. The aim of this study was to evaluate the serum level of cathepsin B and L with aging and their association with matrix metalloproteinase 2 (MMP2), which was reported to associate with age-related diseases. Methods: This research was conducted using blood samples provided by healthy people (n= 90, 63 men and 27 women). Subjects were subdivided into groups with respect to age: young (about 18-30 years old, n= 30), middle age (about 36-50 years old, n= 30), and aged (above 56 years old, n= 30). Altered serum level of cathepsin B, cathepsin L, and MMP2 with aging was studied by enzyme-linked immunosorbent assay (ELISA) and Western blotting using discriminative antibodies specific for each factor. Results: ELISA and Western blotting revealed that the serum level of cathepsin L and MMP2, but not cathepsin B significantly decreased in aged group compared with young group. Cathepsin L positively correlates with MMP2 among the whole healthy people (r2=0.869, p<0.0001). Conclusion: The serum level of cathepsin L decreased with age, while cathepsin B remained no significant difference between young and aged individuals. In addition, cathepsin L positively correlates with MMP2. Practice: The cathepsin L may be used as a monitoring index in age-related diseases. Implications: In addition to cathepsin B, cathepsin L may be also involved in the aging process. © 2015 Elsevier Ireland Ltd.


PubMed | Jin Shan Branch Hospital of Sixth Peoples Hospital of Shanghai and Shanghai JiaoTong University
Type: Comparative Study | Journal: Archives of gerontology and geriatrics | Year: 2015

Most publications describe cathepsin B and L as tumor and metastasis factors. These proteases also play a very important role in aging process. The aim of this study was to evaluate the serum level of cathepsin B and L with aging and their association with matrix metalloproteinase 2 (MMP2), which was reported to associate with age-related diseases.This research was conducted using blood samples provided by healthy people (n=90, 63 men and 27 women). Subjects were subdivided into groups with respect to age: young (about 18-30 years old, n=30), middle age (about 36-50 years old, n=30), and aged (above 56 years old, n=30). Altered serum level of cathepsin B, cathepsin L, and MMP2 with aging was studied by enzyme-linked immunosorbent assay (ELISA) and Western blotting using discriminative antibodies specific for each factor.ELISA and Western blotting revealed that the serum level of cathepsin L and MMP2, but not cathepsin B significantly decreased in aged group compared with young group. Cathepsin L positively correlates with MMP2 among the whole healthy people (r(2)=0.869, p<0.0001).The serum level of cathepsin L decreased with age, while cathepsin B remained no significant difference between young and aged individuals. In addition, cathepsin L positively correlates with MMP2.The cathepsin L may be used as a monitoring index in age-related diseases.In addition to cathepsin B, cathepsin L may be also involved in the aging process.

Loading Jin Shan Branch Hospital of Sixth Peoples Hospital of Shanghai collaborators
Loading Jin Shan Branch Hospital of Sixth Peoples Hospital of Shanghai collaborators